Higher doses of statin may lead to fatal kidney failure
Sunday - Mar 21, 2010, 12:01am (GMT+5.5)
London, Mar 21 (ANI): Higher doses of cholesterol lowering drug Zocor, sold generically as simvastatin, may increase risk of a condition which can lead to fatal kidney failure, a drug watchdog has warned.
According to an analysis of clinical trial data in America, large doses of simvastatin, which is taken in order to lower cholesterol and reduce the risk of having a heart attack, can cause muscle damage and a rare condition which induces kidney problems and may be fatal.
Patients were told not to stop taking simvastatin but advised to talk to their doctor if they have concerns, reports The Telegraph.
The US medicines regulator, the Food and Drug Administration, has issued a warning to patients to be alert to signs of problems when taking the 80mg daily dose of simvastatin.
A spokesman for the Medicines and Healthcare products Regulatory Agency said: "The 80 mg per day dose is only recommended in patients with severe hypercholesterolaemia and at high risk for cardiovascular complications.
"Myalgia (complaints of muscle aches) is a common side effect of statins, including simvastatin. It is recognised that very rarely statins can cause more serious muscle damage (myopathy) which in some cases may be life-threatening.
"There are comprehensive warnings in the product information for prescribers and in the Patient Information Leaflet.
"These warnings advise that the risk of muscle injury is greater: at higher doses of simvastatin; when used in combination with certain other medicines including amiodarone (a medicine used for an irregular heart beat) and other medicines that are recognised to increase the risk of myopathy; and in certain patient groups including those who are more than 70 years old, those with kidney or thyroid problems, those who consume large amounts of alcohol, and those with a history of previous muscle problems during treatment with statins or other lipid lowering drugs.
"As with all marketed medicines the safety of simvastatin is kept under continuous review by the MHRA." (ANI)
| Other Articles: |
 |
Sleep deprivation linked to drug use in teens' social networks (20th Mar, 2010) |
|
Good sleep reduces teenagers’ chances of using drugs: Study (20th Mar, 2010) |
|
Cough medicine ingredient noscapine may help fight prostate cancer (20th Mar, 2010) |
|
Acne drug may help prevent HIV breakout (20th Mar, 2010) |
|
Pesticide chlorpyrifos associated with childhood developmental delays (20th Mar, 2010) |
|
Parents putting babies at risk by using slings incorrectly, say experts (20th Mar, 2010) |
|
Delhiites to queue up outside toilets to spread sanitation message (20th Mar, 2010) |
|
Bone Stem Cells can be used to mend damaged hips (20th Mar, 2010) |
|
Israeli airstrikes wound 10 in Gaza (20th Mar, 2010) |
|
Now, a gel to end misery of cleft palates (20th Mar, 2010) |
|
Genetically modified mosquitos may help fight malaria (20th Mar, 2010) |
|
Will accept nothing short of Headley's extradition: BJP (19th Mar, 2010) |
|
Acupuncture 'can spread HIV, hepatitis B and C' (19th Mar, 2010) |
|
Smoking may impair women's cognition (19th Mar, 2010) |
|
First summit of religious leaders on AIDS in Netherlands (19th Mar, 2010) |
|
Shift workers at increased irritable bowel syndrome risk (19th Mar, 2010) |
|
Women with swine flu more likely to suffer critical illness if pregnant (19th Mar, 2010) |
|
Stress during pregnancy 'ups offspring's asthma risk' (19th Mar, 2010) |
|
Cardiac rehabilitation can help heart patients (19th Mar, 2010) |
|
Exercising? Get your clothes right (19th Mar, 2010) |
|
Democrats unveil US health reform bill (19th Mar, 2010) |
|
Morning-after pill doesn't cut teen pregnancy: Study (19th Mar, 2010) |
|
Loneliness raises blood pressure: research (19th Mar, 2010) |
|
Marathon training 'causes heart damage in healthy people' (18th Mar, 2010) |
|
Calls for melancholia to be listed as 'mental illness' (18th Mar, 2010) |
|
Today : Saturday - May 26, 2012, 12:28am (GMT+5.5)
